These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15756094)

  • 21. Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation.
    Müller-Lissner S; Holtmann G; Rueegg P; Weidinger G; Löffler H
    Aliment Pharmacol Ther; 2005 Jan; 21(1):11-20. PubMed ID: 15644040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of tegaserod on work and daily activity in irritable bowel syndrome with constipation.
    Reilly MC; Barghout V; McBurney CR; Niecko TE
    Aliment Pharmacol Ther; 2005 Sep; 22(5):373-80. PubMed ID: 16128674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials.
    Shah ED; Lacy BE; Chey WD; Chang L; Brenner DM
    Am J Gastroenterol; 2021 Aug; 116(8):1601-1611. PubMed ID: 34047303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tegaserod: long-term treatment for irritable bowel syndrome patients with constipation in primary care.
    Layer P; Keller J; Mueller-Lissner S; Rüegg P; Loeffler H
    Digestion; 2005; 71(4):238-44. PubMed ID: 16024929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serotonin transporter gene polymorphisms in irritable bowel syndrome and their impact on tegaserod treatment].
    Li YY; Nie YQ; Xie J; Tan HZ; Zhou YJ; Wang H
    Zhonghua Nei Ke Za Zhi; 2006 Jul; 45(7):552-5. PubMed ID: 17074108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of tegaserod on colonic transit time in male patients with constipation-predominant irritable bowel syndrome.
    Harish K; Hazeena K; Thomas V; Kumar S; Jose T; Narayanan P
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1183-9. PubMed ID: 17688659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of tegaserod in chronic constipation: a randomized, double-blind, controlled trial.
    Johanson JF; Wald A; Tougas G; Chey WD; Novick JS; Lembo AJ; Fordham F; Guella M; Nault B
    Clin Gastroenterol Hepatol; 2004 Sep; 2(9):796-805. PubMed ID: 15354280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tegaserod for constipation-predominant irritable bowel syndrome.
    Kale-Pradhan PB; Wilhelm SM
    Pharmacotherapy; 2007 Feb; 27(2):267-77. PubMed ID: 17253916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and tolerability of tegaserod in patients with irritable bowel syndrome and diarrhea symptoms.
    Fidelholtz J; Smith W; Rawls J; Shi Y; Zack A; Rüegg P; Lefkowitz M
    Am J Gastroenterol; 2002 May; 97(5):1176-81. PubMed ID: 12014724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An observational study of cholecystectomy in patients receiving tegaserod.
    Brinker A; Schech SD; Burgess M; Avigan M
    Drug Saf; 2007; 30(7):581-8. PubMed ID: 17604409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of tegaserod in constipation dominant irritable bowel syndrome.
    Shah SH; Jafri SW; Gul M; Mohsin A; Afzal MN; Butt JA; Khan I; Naqvi A; Rasheed I
    J Coll Physicians Surg Pak; 2004 Jan; 14(1):21-4. PubMed ID: 14764256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic evaluation of tegaserod vs. placebo in the treatment of patients with irritable bowel syndrome: an analysis of the TENOR study.
    Bracco A; Jönsson B; Ricci JF; Drummond M; Nyhlin H
    Value Health; 2007; 10(4):238-46. PubMed ID: 17645678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tegaserod-associated ischemic colitis.
    DiBaise JK
    Pharmacotherapy; 2005 Apr; 25(4):620-5. PubMed ID: 15977922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study.
    Bardhan KD; Forbes A; Marsden CL; Mason T; Short G
    Aliment Pharmacol Ther; 2004 Jul; 20(2):213-22. PubMed ID: 15233702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does co-administration of a non-selective opiate antagonist enhance acceleration of transit by a 5-HT4 agonist in constipation-predominant irritable bowel syndrome? A randomized controlled trial.
    Foxx-Orenstein AE; Camilleri M; Szarka LA; McKinzie S; Burton D; Thomforde G; Baxter K; Zinsmeister AR
    Neurogastroenterol Motil; 2007 Oct; 19(10):821-30. PubMed ID: 17539894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of tegaserod therapy in patients with irritable bowel syndrome or chronic constipation.
    Al-Judaibi B; Chande N; Gregor J
    Can J Clin Pharmacol; 2010; 17(1):e194-200. PubMed ID: 20410554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association of serotonin transporter genetic polymorphisms and irritable bowel syndrome and its influence on tegaserod treatment in Chinese patients.
    Li Y; Nie Y; Xie J; Tang W; Liang P; Sha W; Yang H; Zhou Y
    Dig Dis Sci; 2007 Nov; 52(11):2942-9. PubMed ID: 17394071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tegaserod in treatment of women with irritable bowel syndrome].
    Munck LK; Ainsworth MA
    Ugeskr Laeger; 2007 Jun; 169(23):2190-2. PubMed ID: 17592683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation.
    Gale JD
    Adv Ther; 2009 May; 26(5):519-30. PubMed ID: 19444393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation.
    Barish CF; Crozier RA; Griffin PH
    Curr Med Res Opin; 2019 Jan; 35(1):81-85. PubMed ID: 30277094
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.